Eyelid mass secondary to injection of calcium hydroxylapatite facial filler.
A 37-year-old woman presented with a 2-month history of fullness and ptosis of the left upper eyelid. Examination revealed a 6-cm x 2-cm mass in the left brow and upper eyelid, and a diffuse mass in the lower eyelid. Marked ptosis of the left upper eyelid and elevation of the left lower eyelid were noted. CT showed masses with a bone-like density in the left eyelid and periorbital soft tissue. A through history revealed that the patient had received calcium hydroxylapatite filler injection for nose augmentation 3 days prior to the development of the eyelid masses. The eyelid masses were excised and pathologically confirmed as calcium hydroxylapatite microspherules surrounded by collagen and histiocytes. Two months after surgery, the eyelid masses and ptosis of the left upper eyelid were completely resolved. To our knowledge, this is the first reported case of eyelid mass after injection of calcium hydroxylapatite facial filler for nose augmentation.
Lee
Min Joung
MJ
Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea.
Sung
Mi Sun
MS
Kim
Nam Ju
NJ
Choung
Ho-Kyung
HK
Khwarg
Sang In
SI
D000328:Adult; D001672:Biocompatible Materials / Q000009:adverse effects*; D001763:Blepharoptosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000601:surgery; D003357:Cosmetic Techniques; D017886:Durapatite / Q000009:adverse effects*; D005129:Eye Foreign Bodies / Q000000981:diagnostic imaging / Q000209:etiology* / Q000601:surgery; D005260:Female; D005548:Foreign-Body Migration / Q000000981:diagnostic imaging / Q000209:etiology* / Q000601:surgery; D006801:Humans; D007267:Injections; D009666:Nose; D015595:Skin Aging / Q000187:drug effects*; D014057:Tomography, X-Ray Computed
D001672:Biocompatible Materials; D017886:Durapatite